Anti-Hypertensive Drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased cardiovascular risk, and reducing blood pressure and the use of the anti-hypertensive drug is recommended which significantly decreases such risks. Hence, factors such as increasing cases of diabetes, hypertension, cardiovascular diseases associated with high blood pressure will directly impact the growth of the global anti-hypertensive market during the forecast period.
To Request a Sample of our Report on Anti-Hypertensive Drugs Market: https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market
However, the high cost associated with
anti-hypertensive drugs will turn out to be a major restraint for the growth of
the anti-hypertensive market, as it has to be given to the patient for a longer
period. Additionally, the low awareness and less diagnosis rate in the
developing countries will also hamper the growth of the anti-hypertensive drugs
market during the forecast period. Moreover, the side effects of
anti-hypertensive drugs such as calcium channel blockers used during pregnancy
include tachycardia, palpitations, peripheral edema, headaches, and facial
flushing, which will lower the adoption of these drugs. Hence, the low adoption
rate of anti-hypertensive drugs during pregnancy will majorly restrict the
growth of the anti-hypertensive drug market during the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of Anti-Hypertensive Drugs Market is Available
at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market
Global
Antihypertensive Drugs Market Segmentation
By Drug Class
·
Thiazide
Diuretics
·
Calcium
Channel Blockers
·
ACE
Inhibitors
·
Angiotensin
II Receptor Antagonists (ARBS)
·
Beta
Blockers
·
Others
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest oF APAC
Rest of The World
Company Profiles
·
AstraZeneca
PLC
·
Bayer
AG
·
Boehringer
Ingelheim International GmbH
·
Daiichi
Sankyo Co., Ltd.
·
Johnson
& Johnson Services, Inc.
·
Lupin
Ltd.
·
Merck
KGaA
·
Noden
Pharma DAC
·
Novartis
International AG
·
Pfizer
Inc.
·
Ranbaxy
Laboratories Ltd.
·
Renata
Ltd.
·
Sanofi
S.A.
·
Sun
Pharmaceuticals LLC
·
Takeda
Pharmaceutical Company Ltd.
·
Teva
Pharmaceutical Industries Ltd.
·
Unichem
Laboratories Ltd.
·
United
Therapeutics Corp.
Reasons to Buying
From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment